** Shares of medical technology company Polynovo PNV.AX slump 8.3% to A$1.265, their lowest since early November 2023
** Co says it held a confidential discussion with CEO Swami Raote requesting the latter's agreement to step down as chief
** The Australian reported that co's chair David Williams was the subject of an independent probe into the alleged bullying of company executives, including Raote and CFO Jan Gielen
** PNV did not provide any further details on why it held a discussion over ending CEO's employment
** Co says if Raote steps down, Robyn Elliott would take up the role of acting chief executive
** Stock down 37.1% YTD
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.